Cor pulmonale is a condition in which the right side of the heart enlarges and weakens because of high blood pressure in the lungs. It is not a primary heart problem. Instead, it develops as a complication of lung disease, most commonly COPD, which accounts for more than 50% of cases. The outlook is serious: among patients with pulmonary hypertension caused by chronic lung disease, the five-year survival rate is roughly 31%.
How Lung Disease Damages the Heart
Your heart has two pumping sides. The left side pushes blood to the body; the right side pushes blood to the lungs. Normally, the right side works against very low resistance because the blood vessels in healthy lungs are wide open and flexible. Cor pulmonale develops when those lung vessels become narrowed, stiffened, or blocked, forcing the right side of the heart to pump much harder than it was designed to.
The chain of events usually starts with low oxygen levels in the blood, a hallmark of chronic lung disease. When oxygen drops, the small arteries in the lungs constrict. Over time, the vessel walls thicken and stiffen permanently. The lungs also lose their natural ability to relax blood vessels because low oxygen reduces production of nitric oxide, a chemical that keeps vessel walls supple. The result is persistently elevated pressure in the pulmonary arteries, now defined as a mean pulmonary artery pressure above 20 mmHg at rest.
Facing this increased resistance day after day, the right ventricle adapts by growing thicker walls, similar to how a muscle bulks up under heavy load. For a while this compensates. Eventually, though, the muscle can no longer keep up. The ventricle stretches, weakens, and begins to fail. Blood backs up into the veins of the body, producing many of the visible symptoms of cor pulmonale.
Common Causes
Any condition that raises pressure in the pulmonary arteries can trigger cor pulmonale. The most frequent causes fall into a few broad categories:
- Chronic obstructive pulmonary disease (COPD): emphysema and chronic bronchitis destroy lung tissue and narrow airways, creating the low-oxygen environment that drives vascular remodeling. COPD is by far the leading cause.
- Interstitial lung disease: conditions like pulmonary fibrosis replace normal lung tissue with scar tissue, compressing blood vessels and raising resistance. Patients with interstitial lung disease tend to have worse survival than those with COPD-related cor pulmonale.
- Obstructive sleep apnea: repeated episodes of airway collapse during sleep cause intermittent drops in oxygen that, over years, contribute to pulmonary hypertension.
- Chronic blood clots in the lungs: clots that don’t fully dissolve can permanently block pulmonary arteries, increasing resistance and leading to cor pulmonale.
- Other conditions: sarcoidosis, blood disorders that thicken the blood (such as polycythemia vera), and inflammation of blood vessels (vasculitis) can all raise pulmonary pressures enough to strain the right heart.
Acute vs. Chronic Cor Pulmonale
Cor pulmonale can develop slowly over months or years, or it can strike suddenly. The chronic form is far more common and follows the gradual vascular remodeling described above. Symptoms creep in as the right ventricle progressively enlarges and loses function.
Acute cor pulmonale is a medical emergency. The most common trigger is a massive pulmonary embolism, a large blood clot that suddenly blocks a major artery in the lungs. An estimated 50,000 deaths per year in the United States result from pulmonary emboli, and about half of those deaths occur within the first hour due to acute right heart failure. Acute respiratory distress syndrome (ARDS), sometimes worsened by mechanical ventilation, is another cause. In acute cases, the right ventricle has no time to adapt. It is abruptly overwhelmed by resistance it cannot overcome, leading to rapid cardiovascular collapse.
Symptoms and Warning Signs
Early cor pulmonale often hides behind the symptoms of the underlying lung disease, making it easy to miss. Shortness of breath during activity is usually the first sign, but since most patients already have a chronic lung condition, they may attribute worsening breathlessness to their existing disease rather than a new heart problem.
As the right ventricle begins to fail, fluid backs up into the body’s venous system. This produces swelling in the ankles, legs, and sometimes the abdomen. The veins in the neck may become visibly distended and pulsate, a sign of elevated pressure in the venous system. The liver can become enlarged and tender as it congests with backed-up blood. Some people develop a bluish tint to the lips or fingers from low oxygen. Fatigue, lightheadedness, and fainting spells during exertion can occur as the heart struggles to maintain adequate blood flow.
In acute cor pulmonale, symptoms appear suddenly and are more dramatic: severe chest pain, rapid breathing, a racing heart, and sometimes shock.
How Cor Pulmonale Is Diagnosed
Diagnosis typically begins when a patient with known lung disease develops signs of right heart strain. An echocardiogram (ultrasound of the heart) is the primary tool. It can show whether the right ventricle is enlarged or thickened and estimate pressures in the pulmonary arteries without an invasive procedure.
An EKG may reveal patterns consistent with right ventricular overload, such as a rightward shift in the heart’s electrical axis or changes in the waveforms that reflect a thickened right ventricle. These findings are suggestive but not always present, especially early on. Chest X-rays can show an enlarged right heart silhouette and prominent pulmonary arteries. Blood tests may reveal elevated levels of a protein called BNP, which the heart releases when it is under stress.
For a definitive measurement of pulmonary artery pressure, a right heart catheterization is sometimes performed. A thin tube is threaded through a vein into the heart and pulmonary artery to directly measure pressures. Pulmonary hypertension is confirmed when mean pulmonary artery pressure exceeds 20 mmHg at rest, a threshold lowered from the previous cutoff of 25 mmHg at the 6th World Symposium on Pulmonary Hypertension in 2018.
Treatment and Management
Because cor pulmonale is driven by the underlying lung condition, treatment focuses primarily on managing that root cause. In COPD patients, this means optimizing bronchodilators, reducing infections, and stopping smoking. In interstitial lung disease, medications that slow scarring may help preserve remaining lung function.
Supplemental oxygen is one of the most important interventions for chronic cor pulmonale. Correcting low blood oxygen levels relieves the signal that causes pulmonary arteries to constrict, reducing the pressure the right ventricle has to work against. Long-term oxygen therapy has been shown to improve survival in COPD patients with chronically low oxygen levels.
Diuretics (water pills) help manage fluid buildup by prompting the kidneys to excrete excess salt and water. This reduces the swelling in the legs and abdomen and lessens the volume of blood the struggling right ventricle has to handle. They require careful monitoring, though, because removing too much fluid can drop blood pressure and reduce the heart’s output.
In cases caused by chronic blood clots, blood thinners help prevent new clots from forming, and some patients are candidates for surgical removal of old clot material from the pulmonary arteries. For patients with severe, progressive disease that does not respond to other treatments, lung transplantation may be considered.
Prognosis and Long-Term Outlook
Cor pulmonale carries a poor prognosis overall, largely because it signals advanced lung disease. Among patients with pulmonary hypertension related to chronic lung disease, one-year survival is approximately 79%, dropping to 48% at three years and 31% at five years, with a median survival of two to five years after diagnosis. Patients whose cor pulmonale stems from interstitial lung disease fare worse than those with COPD, with roughly 43% higher adjusted risk of death.
The trajectory depends heavily on how well the underlying lung disease can be controlled and whether oxygen levels can be maintained. Patients who use supplemental oxygen consistently, stay on top of lung infections, and manage fluid retention tend to have better outcomes. Acute exacerbations of the underlying lung disease are particularly dangerous because each flare-up can push the already-strained right ventricle closer to failure.